M Idea AI Channel Checks Validate Bull Thesis AI channel checks reinforce the bull case for TXG: 11 of 12 KOLs expect higher single-cell or spatial usage, with all academics and 5 of 6 biopharma/CROs positive. Key upside is utilization and consumables growth as AI increases demand for richer biological datasets. August 18, 2026 12:57 PM GMT 10X Genomics Inc | North America Key Takeaways Evident optimism. With enthusiasm continuing to build around 10x Genomics' (TXG's) role in the AI-driven future of life sc ...